The technologies that matter to me are those that can create meaningful change for the greater good — not just projects or prototypes, but breakthrough technologies that can actually scale and make a better future possible.

For over 15 years, I have helped transform breakthrough technologies into global businesses across Europe and China.

From AI and Urban Air Mobility to Biotechnology and Advanced Materials, my focus has always been the same: commercialization, international growth and industrial scale.

Former contributor to EHang’s Nasdaq listing (NASDAQ: EH) and Head of Asian Investment at France’s former No. 1 economic agency, I currently serve as Global Vice President & Head of Strategy at SynMetabio, working to bring next-generation biotechnology and materials from breakthrough science to global markets.